Article
[Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
Rinsho byori. The Japanese journal of clinical pathology - 1 Sept 2015
Kitamura Kouichi, Matsushita Kazuyuki, Kobayashi Souhei, Ishige Takayuki, Semba Toshihisa, Kimura Asako, Kazami Takahiro, Ohyama Masayuki, Itoga Sakae, Beppu Minako, Nishimura Motoi, Satoh Mamoru, Nomura Fumio
Abstract excerpt
Alternative splicing is an important mechanism that links to transcription and contributes to protein diversity. Disturbed alternative splicing is frequently observed in cancers, but its precise mechanism remains largely unknown. FUSE-binding protein (FBP) -interacting repressor (FIR) is a transcriptional repressor of the c-myc gene. Previous studies indicated that a splice variant of FIR, FIRΔexon2, that lacks...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
